Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Aminex Therapeutics, Inc.
ABM Therapeutics Corporation
Hoffmann-La Roche
City of Hope Medical Center
Xennials Therapeutics Australia Pty Ltd
Duke University
Cambridge University Hospitals NHS Foundation Trust
Tocagen Inc.
Vanderbilt-Ingram Cancer Center
CureOne
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Rutgers, The State University of New Jersey
SWOG Cancer Research Network
Case Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center